Literature DB >> 3900395

Penicillamine induced pemphigus.

V C Ho, H B Stein, R A Ongley, W A McLeod.   

Abstract

Three cases of penicillamine induced pemphigus are described and compared to 35 previously reported cases with typical direct immunofluorescence. The incidence in our clinic was 0.57%. The penicillamine dose ranged from 250 to 1500 mg/day and the mean duration of treatment was 11 months at the onset of pemphigus in the 38 cases. Morphology and immunopathology was indistinguishable from spontaneously occurring pemphigus. The majority of cases resolved within 4 months after stopping, penicillamine; however, 8 cases, including 2 in this report, have persistent pemphigus.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3900395

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  2 in total

1.  Penicillamine induced pemphigus--a report of 2 cases.

Authors:  C Buckley; C Barry; R Woods; P Dervan; S O'Loughlin
Journal:  Ir J Med Sci       Date:  1988-08       Impact factor: 1.568

2.  Bucillamine-induced pemphigus vulgaris in a patient with rheumatoid arthritis and polymyositis overlap syndrome.

Authors:  Jin-Wuk Hur; Chang-Woo Lee; Dae-Hyun Yoo
Journal:  J Korean Med Sci       Date:  2006-06       Impact factor: 2.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.